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Summary
We report the cDNA cloning, chromosomal localization,
and a mutation in the human nuclear gene encoding the
18-kD (AQDQ) subunit of the mitochondrial respiratory
chain complex I. The cDNA has an open reading frame
of 175 amino acids and codes for a protein with a mo-
lecular mass of 23.2 kD. Its gene was mapped to chro-
mosome 5. A homozygous 5-bp duplication, destroying
a consensus phosphorylation site, in the 18-kD cDNA
was found in a complex I–deficient patient. The patient
showed normal muscle morphology and a remarkably
nonspecific fatal progressive phenotype without in-
creased lactate concentrations in body fluids. The child’s
parents were heterozygous for the mutation. In 19 other
complex I–deficient patients, no mutations were found
in the 18-kD gene.
Introduction
Among the inborn errors of metabolism, disturbances
in the mitochondrial energy metabolism form a quan-
titatively major group, occurring in 1/10,000 live births
(Bourgeron et al. 1995). In case of a defective pyruvate
oxidation, skeletal muscle and brain tissue are often in-
volved. In these mitochondrial encephalomyopathies
(OMIM 251900[http://www3.ncbi.nlm.nih.gov:80/
htbin-post/Omim/dispmim?251900]), the most fre-
quently observed enzyme deficiencies are located in the
pyruvate dehydrogenase complex and complexes I
(OMIM 252010 [http://www3.ncbi.nlm.nih.gov:80/
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htbin-post/Omim/dispmim?252010]) and/or IV of the
respiratory chain (Wallace 1992; Ruitenbeek et al.
1996). Numerous patients with isolated complex I de-
ficiency have been reported (Korenke et al. 1990;
DiMauro 1993; Shoffner et al. 1994). Their clinical pres-
entation in general is that of a very severe, often fatal,
multisystemic disorder frequently dominated by brain
and skeletal muscle abnormalities. Less severe pheno-
types have also been described (Wallace 1992; Trijbels
et al. 1996). Until now, only one mutation in a nuclear
gene has been described in a patient with a defective
respiratory chain enzyme complex: a point mutation in
the flavoprotein (FP) subunit of complex II (Bourgeron
et al. 1995). No mutations in the nuclear genome of one
of the other respiratory chain complexes have been re-
ported. The relatively high frequency of complex
I–deficient patients prompted us to investigate the mo-
lecular cause of this enzyme deficiency.
Complex I or NADH:ubiquinone oxidoreductase, the
first multisubunit enzyme complex of the mitochondrial
respiratory chain, plays a vital role in cellular ATP pro-
duction, the primary source of energy for many crucial
processes in living cells (Walker 1992; Pilkington et al.
1993; Trijbels et al. 1996). It removes electrons from
NADH and passes them via a series of different protein-
coupled redox centers (FMN and FeS clusters) to the
electron acceptor ubiquinone (Yamaguchi and Hatefi
1993). In well-coupled mitochondria, the electron flux
leads to ATP generation via the building of a proton
gradient over the inner membrane.
Complex I is composed of x41 subunits, of which 7
are encoded by the mitochondrial genome (ND1-6,
ND4L) and the remaining by nuclear genes (Fearnley
and Walker 1992). Limited information is available con-
cerning the precise location and function of the individ-
ual subunits. Very recently, a low-resolution three-di-
mensional structure of complex I from Neurospora
crassa has been elucidated (Guenebaut et al. 1997). A
number of different subunits contribute to binding sites
for FMN, NADH, and 4Fe-4S and 2Fe-2S centers (Wal-
ker 1992; Pilkington et al. 1993). It is hypothesized that
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subunits of the FP fraction play a role in FMN and
NADH binding. Proteins in the IP (iron-sulfur protein)
fraction likely function in reduction-oxidation reactions
via different iron-sulfur clusters. Very recently, it has
been shown that the nuclear-encoded 18-kD (AQDQ)
subunit of bovine heart complex I can be phosphorylated
by a mitochondrial cyclic adenosine 53-monophosphate
(cAMP)–dependent protein kinase (Papa et al. 1996). It
is well established that the 18-kD (AQDQ) subunit is in
the extrinsic domain of complex I (Walker 1992).
In some patients (i.e., in Leber hereditary optic neu-
ropathy) a mutation in the ND4 subunit of the mito-
chondrial genome has been established (Brown et al.
1997). So far, the human cDNA sequences of seven nu-
clear-encoded subunits (i.e., 75 kD, 51 kD, 24 kD, B22,
B13, PSST, and NDUFA1) have been published (Chow
et al. 1991; Spencer et al. 1992; De Coo et al. 1995;
Hattori et al. 1995; Gu et al. 1996; Hyslop et al. 1996;
Zhuchenko et al. 1996; Pata et al. 1997). The availability
of the bovine cDNA sequence for the 18-kD (AQDQ)
protein (Walker et al. 1992) enabled us to apply a PCR-
based strategy for generating the cDNA for the human
18-kD protein from human heart.
In this article, we present the human cDNA sequence
of the nuclear-encoded 18-kD subunit, the chromosomal
localization of the gene, and the results of mutation de-
tection in 20 complex I–deficient patients all exhibiting
a multisystem disorder. Detailed information is pre-
sented about the clinical symptoms of one patient in
whom we found a 5-bp duplication in the 18-kD gene.
This is the first report of a pathological mutation in a
nuclear complex I gene of the mitochondrial respiratory
chain.
Subjects and Methods
Case History
A male patient, born after an uncomplicated preg-
nancy as the second child of healthy nonconsanguineous
Caucasian parents, was first admitted at the age of 8 mo
with severe vomiting, failure to thrive, and hypotonia.
Despite supportive care, his clinical condition deterio-
rated in the following months. At the age of 13 mo, he
showed severe psychomotor retardation, convulsions,
bradypnea, cyanosis, hypotonia, and depressed tendon
reflexes. Results of routine clinical chemical blood and
urine investigations, as well as amino-acid and organic-
acid analyses in blood and urine, were normal. Lactic
acid concentrations in blood and cerebrospinal fluid
were within the range of controls. Electromyographic
parameters were normal. Cerebral magnetic resonance
imaging revealed generalized brain atrophy and sym-
metrical basal ganglia abnormalities. When the patient
was 14 mo of age, a skeletal muscle biopsy (musculus
quadriceps femori) was performed to investigate the mi-
tochondrial energy-generating system (see Biochemical
Methods). Light and electron microscopy and histo-
chemistry did not reveal abnormalities. No ragged-red
fibers were present. The child’s condition deteriorated
severely, and he died of cardiorespiratory failure at the
age of 16 mo. The family history is normal for neuro-
muscular disorders. A younger brother and older sister
of the proband are healthy.
Biochemical Methods
A biopsy of the patient’s quadricep muscles was per-
formed when he was 14 mo of age. Mitochondrial en-
zyme activities were determined inmitochondria isolated
from frozen tissue, as described previously by Elpeleg et
al. (1997). Respiratory chain enzyme activities in fibro-
blasts, cultured in M199 medium until confluency, were
determined in mitochondria-enriched fractions as de-
scribed by Bentlage et al. (1996). Enzyme assays were
essentially identical to those described by Fischer et al.
(1986) for skeletal muscle.
Cloning of the Human 18-kD cDNA
Human 18-kD cDNA was obtained by reverse tran-
scription using oligo(dT) and random hexamer primers
on poly ARNA isolated from human heart (Clonetech).
PCR amplification was performed with cDNA as tem-
plate according to the protocol for Taq polymerase (Life
Technologies) by use of oligonucleotides 5′-ATG GCG
GCGGTC TCAATGTC-3′ and 5′-CTA TTT TGTGGA
TAC TCT TCT TC-3′. Oligonucleotide sequences were
based on homology with bovine 18-kD cDNA sequence
(Walker et al. 1992) and known human expressed se-
quence tags (ESTs). The PCR product was purified for
direct DNA sequencing. DNA sequence analysis of both
DNA strands was performed using the dyedeoxy-ter-
minators on an automated ABI 377 sequencer according
to a protocol provided by the manufacturer (Applied
Biosystems).
Chromosomal Localization of the 18-kD Gene
Genomic DNA was isolated from human-rodent so-
matic cell hybrids containing all 24 human chromo-
somes (Coriell Cell Depositories) digested with EcoRI,
fractionated, and blotted to Hybond nylon membrane.
The blot was hybridized with a32P-dCTP–labeled human
18-kD cDNA probe (of 528 bp). Binding of the probe
was visualized by autoradiography.
Mutation Detection
Total RNA was extracted (Chomczynski and Sacchi
1987) from cultured skin fibroblasts (Bentlage et al.
1996) and stored as ethanol precipitate at 80C. A 5-
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Table 1
Enzyme Activities in Skeletal Muscle and Fibroblasts
ENZYME ACTIVITY
Patient Control Range
Skeletal muscle:
Cytochrome c oxidase 7.2a 2.8–11.8a
NADH:ferricyanide
oxidoreductase 1.16b 1.7–4.1b
NADH:cytochrome c
reductase 27.0c 63–529c
Succinate:cyt c
oxidoreductase 100.0c 39–249c
Citrate synthase 1.28b 1.0–2.1b
Mg2-ATPase 634.0d 213–553d
Pyruvate
dehydrogenase
complex 18.3c 27–61c
Fibroblasts:
NADH:Q1
oxidoreductase .075e .10–.26e
Succinate:cyt c
oxidoreductase .23e .21–.44e
Decylubiquinol:cyt c
oxidoreductase 1.22e 1.25–2.62e
Cytochrome c oxidase 239.0c 147–252c
Citrate synthase 311.0c 144–257c
a In k/mg protein.
b In U/mg protein.
c In mU/mg protein.
d In mU/g protein.
e In mU/mU cytochrome c oxidase.
mg sample of RNA was reverse transcribed to cDNA in
1 h at 42C with 200 U of Superscript II reverse tran-
scriptase (RT) (Life Technologies), using oligo(dT) and
random hexamer primers. One microliter of cDNA was
subjected to PCR amplification. By PCR we generated
one fragment covering the entire coding region, using
the synthetic oligonucleotide primers described before.
The PCR program consisted of 35 cycles of 30 s at 94C,
30 s at 55C, and 1 min at 72C. The cycles were pre-
ceded by an initial denaturation step of 3 min at 95C
and were followed by a final extension of 10 min at
72C. The PCR reaction was analyzed on a 1.0% aga-
rose gel with 0.5 mg/ml ethidium bromide in 1 # Tris-
borate EDTA. The nucleotide sequences of the PCR
products were analyzed by direct sequencing using the
Taq Dye Deoxy terminator cycle sequencing kit accord-
ing to the manufacturer’s recommendations (Applied
Biosystems).
To confirm the mutation at the genomic DNA level,
a fragment consisting of 96 bp was amplified in the same
PCR buffer as described above, using forward primer
5′-TAT GAC ATT GAA GAG AGG AAG G-3′ and re-
verse primer as decribed above. PCR fragments were
resolved in a 20% polyacrylamide gel. Ethidium bro-
mide was used to visualize the PCR fragments, and the
presence of the duplication could be checked by size.
Results
Biochemical Results
From the decreased activity of NADH:ferricyanideox-
idoreductase as well as NADH:cytochrome c reductase,
a deficiency in complex I in skeletal musclemitochondria
can be concluded (see table 1). The NADH:Q1 oxido-
reductase assay revealed a complex I deficiency in cul-
tured skin fibroblasts also. The activities of the other
respiratory chain enzyme complexes and Mg2-ATPase
were all normal.
Cloning of the Human 18-kD cDNA
We obtained a 528-bp cDNA fragment of the human
nuclear-encoded 18-kD gene by RT-PCR using human
heart RNA and oligonucleotide primers based on the
18-kD cDNA sequence from cow (Walker et al. 1992)
and known human ESTs (Adams et al. 1995). Sequence
analysis of the human 18-kD cDNA clone revealed an
open reading frame of 175 amino acids (fig. 1). The
amino acid sequence showed 91% homology with the
bovine 18-kD amino acid sequence (data not shown).
The calculated molecular weight of the protein encoded
by the human 18-kD cDNA is 23.2 kD. As in the cow,
the protein contains a leader sequence (amino acids
1–42) for import into the mitochondria. In the cow, this
signal peptide is removed after import. There is a phos-
phorylation consensus site (RVS) at amino acid positions
171–173 (Pearson and Kemp 1991; Kemp et al. 1994).
The human protein has no cysteine residues.
Chromosomal Localization of the Human 18-kD Gene
A Southern blot with genomic DNA from human-
rodent somatic cell hybrids containing all human chro-
mosomes has been used for hybridization with human
18-kD cDNA as probe. A specific hybridization signal
was detected only for chromosome 5, indicating that the
nuclear-encoded 18-kD (AQDQ) gene maps to this chro-
mosome (fig. 2).
Mutation Detection in the Human 18-kD Subunit
A template of human cDNA was produced by first-
strand synthesis of human fibroblast RNA originating
from 20 patients with a complex I deficiency enzymat-
ically established in fibroblasts and, when available, also
in skeletal muscle and other tissues. One set of oligo-
nucleotide primers enabled us to amplify the entire cod-
ing region of the 18-kD cDNA. Direct sequencing of this
region revealed a novel homozygous 5-bp duplication of
the cDNA sequence at positions 466–470 (AAGTC) in
one patient (fig. 3A). No other sequence aberrations
could be detected in the 18-kD cDNA of all other pa-
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Figure 1 Human cDNA sequence for the nuclear-encoded 18-kD (AQDQ) subunit of mitochondrial NADH:ubiquinone oxidoreductase.
Nucleotide sequence of the human 18-kD cDNA (upper line). Deduced amino acid sequence of the open reading frame of 525 bp (175 codons)
is shown on the second line. The cDNA sequence and deduced amino acid sequence have been submitted to GenBank.
Figure 2 Chromosomal location of the human 18-kD (AQDQ) gene. The 18-kD gene was localized to chromosome 5 by chromosomal
somatic cell hybrid analysis. Genomic DNA was isolated from a panel of mouse or hamster/human cells, each containing a single human
chromosome. The DNA was digested with EcoRI, fractionated, transferred to Hybond nylon, and probed with a 528-bp 18-kD cDNA. A
positive signal was observed in the sample of total DNA of human origin (left arrow). Mouse and hamster genomic DNA showed no 18-kD
signal. A strong signal for 18 kD was seen only on hybrids containing chromosome 5 (right arrow).
tients. The 5-bp duplication results in a frameshift at
codon K158 and destroys a phosphorylation site present
at the carboxy terminus of the 18-kD protein. Further-
more, the duplication changes the amino acid sequence
of the 18-kD protein from amino acid 158 to the car-
boxy terminus and expands the length of the protein by
14 amino acids (fig. 3B). The mutation was confirmed
on the genomic DNA level by PCR combined with
PAGE. Both parents appeared to be heterozygous for the
mutation (fig. 4). The segregation of this mutation in
the family is consistent with an autosomal recessive
mode of inheritance. The duplication was not present in
100 control alleles and the 19 other complex I–deficient
patients.
Discussion
Complex I deficiencies, whether or not as part of mul-
tiple enzyme deficiencies, are a major cause of mito-
chondrial encephalomyopathies. So far, no mutation in
a nuclear gene of one of the numerous complex I sub-
units has been described. The multisystemic progressive
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Figure 3 A, DNA sequence of 18-kD cDNA segments for wild
type (top) and patient with the mutation (bottom). For the patient, a
5-bp duplication (AAGTC) was observed, resulting in a frameshift and
extension of the C-terminus of the 18-kD protein. B, Primary C-ter-
minal amino acid sequence of wild-type and patient’s 18-kD protein.
Figure 4 Molecular analysis of the 18-kD (AQDQ) gene. Seg-
regation of the 5-bp duplication in the 18-kD gene in the family, de-
tected by PCR on genomic DNA and by PAGE. Mutant and wild-type
alleles are 101 bp and 96 bp, respectively. Lane 1, Molecular weight
markers. Lane 2, Brother. Lane 3, Father. Lane 4, Mother. Lane 5,
Index patient.
clinical presentation of our patient was highly suggestive
for a mitochondriocytopathy (Munnich et al. 1992;
DiMauro 1993; Schoffner et al. 1994; Ruitenbeek et al.
1996). Despite normal clinical chemical features, bio-
chemical analyses indeed revealed a reduced complex I
activity both in skeletal muscle and cultured skin fibro-
blasts. In addition, a 5-bp duplication in the cDNA and
genomic DNA encoding the nuclear-encoded 18-kD
(AQDQ) subunit of complex I of the respiratory chain
could be demonstrated. Both parents were heterozygous
for this mutation.
We started our mutation analysis in complex
I–deficient patients with examination of the 18-kD
(AQDQ) gene, because Papa et al. (1996) recently found
that the bovine 18-kD subunit can be phosphorylated.
A mitochondrial inner membrane–bound kinase acts via
a cAMP-dependent mechanism. The presence of a phos-
phorylation/dephosphorylation site is frequently asso-
ciated with regulation of biological processes. In the case
of phosphorylation of the 18-kD subunit, one can hy-
pothesize an influence on complex I activity or a role in
posttranslational processes. The cDNA, encoding the
18-kD subunit of bovine complex I, had already been
cloned. We cloned the human 18-kD subunit by RT-
PCR, using human heart mRNA as template. The pro-
tein encoded by the human 18-kD gene is 175 amino
acids long, and its calculated molecular mass is 23.2 kD.
The amino acid sequences of the human and bovine 18-
kD protein are highly conserved. There is ∼91% identity
between these two species. The phosphorylation con-
sensus site (RVS) is also present in the human subunit.
As in the cow, the human 18-kD (AQDQ) subunit has
a leader sequence for import into the mitochondria. Al-
though the human, like the bovine, 18-kD protein is
supposed to be part of the IP fraction (Walker et al.
1992), it has no cysteine residues that might provide
ligands for iron-sulfur centers. A Blast search for ho-
mologous sequences revealed two different EST clones
(AA258924 and N29566) originating from different hu-
man tissues. The EST clones, whose functions are not
known, have sequences homologous with different parts
of the 18-kD protein.
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We have included in this study 20 patients with a
complex I deficiency in fibroblasts and, in most patients,
in at least one other tissue as well. Direct sequencing of
the entire 18-kD cDNA of these patients revealed in one
patient a homozygous 5-bp duplication. A mistakemade
by the RT or Taq DNA polymerase in the RT-PCR was
excluded by repeating the RT-PCR and DNA sequencing
of this patient and three controls in three independent
experiments, all of which revealed the homozygous du-
plication in the patient’s cDNA. The presence of the
duplication in the patient was confirmed on the genomic
DNA level. The 5-bp duplication causes a shift in the
translational reading frame. The shift results in (1) an
elongation of the mature protein by 14 amino acids and
(2) destroys the phosphorylation consensus site. Al-
though the gene product belongs to the IP fraction and
therefore is probably involved in crucial redox reactions,
its relation to the adjacent subunits and its exact function
are still obscure. Our results, a mutation with an au-
tosomal recessive mode of inheritance, associated with
a fatal multisystemic complex I deficiency biochemically
established in two different tissue types, stress the phys-
iological importance of this subunit in humans. Because
the phosphorylation site in the 18-kD subunit is dis-
rupted in the patient, we speculate that the mutation in
this vital site for regulation of protein function in eu-
karyotic cells is responsible for the observed complex I
deficiency. Alternatively, the obviously changed C-ter-
minus of the 18-kD subunit of the patient has caused
the complex I deficiency. The protein has been elongated
by 14 amino acids, whereas amino acids 158–175 have
been modified. A proper transport and/or folding and
orientation of the 18-kD protein in the enzyme complex
or in the mitochondrial inner membrane may be hin-
dered. Perhaps the alterations in the patients 18-kD su-
bunit also lead to instability and premature breakdown
of the protein.
In conclusion, we present the first mutation in a nu-
clear gene of one of the subunits of complex I of the
human respiratory chain. Although the frequency of the
described mutation must be further established, the find-
ing improves the potentials for genetic counseling and
prenatal diagnosis. These preventive tools are of utmost
importance, because therapeutic intervention is unsuc-
cessful in the majority of complex I patients. Mutation
analysis of other nuclear genes in patients with a com-
plex I deficiency are in progress.
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